Controlled Substances
Opioids
For more information, see pain control
Benzodiazepines
General information
- Include benzodiazepine receptor agonists, e.g. zolpidem (Ambien), zaleplon (Sonata), eszopiclone (Lunesta) 
- Effectively treat generalized/social anxiety, panic disorder, sleep disorders when prescribed at low doses for a short period of time (< 30 days) - Choosing wisely: Don’t use benzodiazepines or other sedative-hypnotics in older adults as first choice for insomnia, agitation, or delirium 
 
Risks
- Risks while driving: Same as BAC between 0.050% and 0.079% 
- Long term use: Substantial cognitive decline that did not resolve 3 months after discontinuation 
- May be appropriate for seizure disorders, rapid eye movement sleep disorders, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, periprocedural anesthesia, end-of-life care 
- Avoid benzodiazepines (any type) for treatment of insomnia, agitation, or delirium due to increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle accidents (SOR Strong) 
- Benzodiazepine-receptor agonists - Adverse events are similar to those of benzodiazepines in older adults 
- Avoid chronic use, i.e. > 90 days (SOR Strong) 
 
 
Agents with Primary Care Prescribing Suggestions
Use
- Anxiety: Benzodiazepines are NOT first line (SSRIs, SNRIs are) 
- Insomnia: Effect diminishes after a few weeks 
- Seizure disorder: Should be managed by neurology 
Start taper for any patient taking daily benzodiazepines for > 1 month, especially:
- Age > 65 years 
- If also taking opioids or amphetamines 
- In patients with history of a substance abuse, cognitive disorder, and/or TBI 
Codes
- Code A - Panic Disorder 
- Code B - Behavior/Attention Deficit 
- Code C - Chronic Debilitation/Neurological Disorder/Seizures etc 
- Code D - Chronic pain/Incurable 
- Code E - Narcolepsy 
- Code F - Hormone Deficiency/Metastatic Breast Cancer